A sector's credibility infrastructure cracks when the outlets that exist to amplify its announcements begin hedging. CodeBlue's question — whether AI hype in drug development is turning into reality [16] — is the kind of framing that trade publications reserve for moments when the gap between announcement and outcome has become impossible to paper over with the next press release. The piece ran alongside Insilico Medicine's branded showcase and a World Economic Forum explainer , both of which represent the established promotional machinery. The juxtaposition is not accidental —…